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Abstract 
Background: Approximately 1 in 5 medical patients have an underlying alcohol use disorder. Purpose: The purpose of this capstone project 
is to determine if standardization of the current clinical processes and assessment tools utilized for the alcohol withdrawal patient population 
contribute to improved patient outcomes as evidenced by a reduction in the overall cost to the organization in treating the substance abuse population 
on a non-psychiatric unit. Cost reduction will be measured by the number of transfers to a higher level of care and length of stay. Methods: The 
Symptom Management Theory Model was used as the framework for the project to facilitate timely patient assessment and interventions and to 
standardize the overall clinical management of the patient requiring alcohol detoxification. The symptom experience concept was the foundation for 
the development of a patient screening tool administered in the emergency department that requires the active participation of the patient and is 
utilized by providers to ensure timely interventions, prevent complications, and improve patient safety and care. Symptom experience includes vital 
signs, a history of alcohol withdrawal seizures or delirium tremens, and a history of required transfer to ICU in the past related to a complicated 
withdrawal. The symptom management concept was the foundation for the development of a standardized physician alcohol detoxification order set. 
Symptom management strategies include triage to the appropriate setting, early initial and ongoing patient assessment, and initiation of the Clinical 
Institute Withdrawal Assessment for Alcohol (CIWA-Ar) protocol and Moderate Detoxification Order Set. The symptom status outcomes concept 
was the foundation for evaluating the impact on transfers to a higher level of care, length of stay, development of alcohol withdrawal complications, 
restraint use, and patient aggression. Evaluation: To determine the effectiveness of the new program, a comparison of the patients treated with the 
new program for a six month period compared to those treated six months prior to program implementation will be conducted to evaluate the impact 
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of implementing a new patient risk assessment, standardized Moderate Detox Order Set and a symptom-triggered (CIWA-Ar) approach on restraint 
usage, number of transfers to a higher level of care, and length of stay over a twelve month period. Recommendations: A standardized clinical 
process, assessment, and order set will improve the quality of care and decrease the associated cost of treating individuals requiring alcohol 
detoxification.  
Background  
  
Alcohol and drug abuse is a public health concern. Approximately 129 million Americans drink alcohol and 22 million of them had drug and 
alcohol problems in 2010 (Sarff & Gold, 2010; US Department of Health and Human Services, Office of Disease Prevention and Health Promotion, 
2010).  In a recent survey, 58 million people reported binge drinking at least once within 30 days before surveyed and 17.3 million people report 
heavy drinking (Sarff & Gold, 2010). 
Substance abuse and dependence are costly, not only to the individual, but to society overall (McCormack et al., 2013; Lotfipour et al., 2013; 
Sarff & Gold, 2010). Epidemiologic studies have identified chronic alcohol consumption as a risk factor for the development of liver, colon, prostate, 
breast, respiratory and upper digestive tracts cancers (Antoine, Christophe & Nandrino, 2009; Lotfipour et al., 2013; Seitz & Maurer, 2007).  The 
financial cost of alcohol abuse to society in the US in the form of crime, lost work productivity, and healthcare is $235 billion dollars annually (US 
Department of Health and Human Services, Office of Disease Prevention and Health Promotion, 2010). The cost to healthcare alone is $30 billion 
dollars annually (US Department of Health and Human Services, Office of Disease Prevention and Health Promotion, 2010). Emergency department 
visits related to alcohol have increased 18% from 1992 to 2000 (Lotfipour et al., 2013).   
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Various forms of stigma serve as barriers to treatment-seeking for substance use disorders. For example, public stigma and organizational 
stigma limit funding and availability of needed services in the community (Pescosolido et al., 2010). Self-stigma includes embarrassment and a 
negative view of self. It contributes to avoidance of treatment-seeking, underestimation of use, and relapse after discharge (Corrigan & Watson, 
2007). Social stigma relates to family member embarrassment and avoidance of the individual. The result is isolation and a loss of social support for 
the individual (Ahmedani et al., 2013; Corrigan, Edwards, Green, Diwan, & Penn, 2001). Stigma contributes to low utilization rates of mental health 
and substance abuse services and an underestimation of use in hospitalized patients (Ahmedani et al, 2013; Gulliver, Griffiths & Christensen, 2010; 
Jagdeo, Cox, Stein, & Sareen, 2009).  
Given that nearly 1 in 5 medical patients have an underlying alcohol use disorder, implementing interdisciplinary interventions to improve the 
early identification of those at risk for alcohol withdrawal complications will enable clinical staff to proactively manage patient symptoms, decrease 
organizational costs, and most importantly improve patient safety.  
Literature Review 
Identified themes from a review of the literature include an increase in the number of individuals diagnosed with mental illness and substance 
abuse or dependence (Sarff & Gold, 2010; US Department of Health and Human Services, Office of Disease Prevention and Health Promotion, 
2010), the individual and societal cost of substance abuse and dependence (McCormack et al., 2013; Lotfipour et al., 2013; Sarff & Gold, 2010; US 
Department of Health and Human Services, Office of Disease Prevention and Health Promotion, 2010), and the negative effect of stigma on mental 
health and substance abuse treatment-seeking (Ahmedani et al, 2013; Corrigan, Edwards, Green, Diwan, & Penn, 2001; Gulliver, Griffiths & 
Christensen, 2010; Jagdeo, Cox, Stein, & Sareen, 2009).  
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 Given the high prevalence of hospitalized patients at risk for alcohol withdrawal compared to those actually identified and treated, it is clear 
that many at risk individuals are not being identified. The cost of treating the substance abuse population and the increased length of stay when 
alcohol withdrawal complications develop, make this project important not only from a financial perspective, but from a quality of care, community, 
and individual health perspective as well. Performing a risk assessment on every individual presenting in the emergency department and educating 
them about the risks of alcohol withdrawal in a non-judgmental manner will minimize the perceived stigma and facilitate honest patient disclosure of 
actual use.      
Although there has been extensive research focused on specific interventions in the emergency department and ICU settings (Aseltine, 2010; 
Awissi, Lebrun, Coursin, Riker, & Skrobik, 2013; Bernstein et al., 2013; Eggers et al., 2002; Finn, 2012; Hungerford & Pollock, 2002; Lotfipour et 
al., 2013; Watson et al., 2013) future research is needed in managing alcohol withdrawal in patients with concurrent medical illness treated on 
medical units. Current research on alcohol use disorders demonstrates the negative impact on individual health and the associated cost to healthcare 
organizations and society (Antoine, Christophe & Nandrino, 2009; Finn, 2012; McCormack et al., 2013; Seitz & Maurer, 2007; Stephens et al, 2014). 
The research is consistent in their findings that individuals with alcohol use disorders have an increased risk of developing various types of cancer, 
account for high percentage of emergency department visits and hospital stays, and have a higher mortality rate (Lotfipour et al., 2013; Stephens et 
al, 2014). Areas for future research include the reasons for increased substance abuse in our society, barriers to treatment-seeking and 
underestimation of use, clinical staff attitudes and communication and its impact on patient disclosure of use, and the integration of medical and 
psychiatric care (McCormack et al., 2013).  
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The literature supports a symptom-triggered approach over a fixed approach to medication management for alcohol withdrawal symptoms 
(Eggers et al., 2002; Sarff & Gold, 2010). A symptom-triggered approach supports administering benzodiazapines when alcohol withdrawal 
symptoms such as anxiety, diaphoresis, headache, hand tremor, nausea, vomiting and psychomotor agitation are present. The Clinical Institute 
Withdrawal Assessment for Alcohol (CIWA-Ar) protocol is an example of a symptom-triggered approach. The CIWA-Ar protocol is currently 
utilized in our community hospitals. The CIWA-Ar is a 10-item scale with each item rated on a 7-point scale, with the exception of orientation, 
which is rated on a 4-point scale. Finn (2012) points out that although the CIWA-Ar is the most widely utilized scale, it has not been validated in 
patients with medical comorbidities. Sarff & Gold (2010) and Awissi, Lebrun, Coursin, Riker, & Skrobik (2013) also address the fact that the CIWA-
Ar was validated on detoxification units with young patients who had no other medical comorbidities and yet is being utilized in settings and with 
populations, such as in the ICU and with trauma or post-surgery patients, where it has not been validated. Withdrawal symptoms can rapidly progress 
to include seizures, visual, tactile, or auditory hallucinations and the development of DTs which consists of hypertension, fever, tachycardia, and 
delirium (Elliott, Geyer, Lionetti, & Doty, 2012).  The patient population requiring alcohol detoxification on medical surgical, post-operative, 
telemetry, and intensive care units have medical co-morbidities with associated symptoms that mirror those of alcohol withdrawal syndrome (Sarf & 
Gold, 2010; Stephens et al, 2014). This complicates the clinical management of the patient and requires practitioners to closely observe patients.  
Patients with compromised health obviously represent a higher risk for experiencing alcohol withdrawal complications (Stephens et al). 
Advantages of a symptom-triggered approach are that patients are not over nor under medicated. The amount of medication administered 
depends on the presentation of symptoms. An advantage of a symptom-triggered over a fixed-dose approach using benzodiazepines is that symptoms 
are managed with a lower overall dose of benzodiazepines. Decreasing the amount of benzodiazepines utilized reduces the risk of over-sedation, 
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patient falls, respiratory depression, and cost (Sarff & Gold, 2010). Over-medication increases the risk of sedation and patient falls. Under-
medication increases the risk of patient aggression toward caregivers and poor clinical outcomes including the development of delirium tremens and 
death. A disadvantage of a symptom-triggered approach is that it is reactive rather than proactive. It is only after individuals have a significant 
decline in their physical and mental status, such as unstable vital signs, agitation, combativeness, and confusion, that nursing interventions are 
implemented. Proper medication management depends on regular RN assessment, early recognition of symptoms and significant changes in mental 
status, and timely initiation of the CIWA-AR protocol. A proactive approach includes an improved initial nursing and MD patient assessment for 
those at risk for alcohol withdrawal complications that is initiated in the emergency department prior to admission to an inpatient unit. 
Stephens et al (2014) developed a standardized protocol for their hospitalists to determine if individuals presenting in the emergency 
department requesting alcohol detoxification should be referred to inpatient or outpatient. Although no statistically significant difference was found 
in length of stay or re admission rate (p=0.09; p=0.33), the reduction in inpatient detoxification admissions from 18.9 to 15.9 (p=0.037) was 
statistically significant. The reduction in inpatient detoxification admissions by three a month, resulted in approximately $315k of cost savings to the 
hospital annually. While their focus was on the setting and its impact on patient outcomes, our focus is on the timing of CIWA-Ar protocol initiation 
and its impact on patient outcomes. Our protocol is primarily intended to identify those individuals at highest risk of developing alcohol withdrawal 
complications and facilitating earlier initiation of the CIWA and associated clinical and pharmacological interventions.  
Predictors of DTs from three studies included 1. an individual with concurrent medical illness, 2. a heart rate greater than 100 and a history of 
prior DTs, and 3. concurrent infectious disease, a heart rate greater than 120, and autonomic signs of withdrawal while legally intoxicated (Stephens 
et al, 2014). It is widely recognized that patients who developed alcohol withdrawal symptoms greater than 48 hours after their last drink, those with 
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prolonged alcohol misuse and withdrawal history, and patients with a blood alcohol level greater than 100mg/dL and a history of tachycardia, 
delirium, and seizures have a higher propensity for severe alcohol withdrawal symptoms (Elliot et al, 2012; Stephens et al, 2014). An individual who 
appears alert and oriented and denies or minimizes alcohol use but who has a legally intoxicated blood alcohol level should alert clinical staff to 
initiate a more in-depth assessment of their substance use history, duration, and current use. Patient education about the potential life-threatening 
consequences of under-reporting use and alcohol withdrawal should be initiated.  
A fixed approach to medication management for alcohol withdrawal symptoms should not be utilized in an inpatient setting.  A combination 
fixed and symptom-triggered approach should be utilized. Stephens et al (2014) recommend a fixed approach only for patients receiving alcohol 
detoxification in an outpatient setting who have a history of alcohol withdrawal seizures and/or DT’s. A fixed-approach to medication management 
for alcohol withdrawal symptoms consists of scheduled dosing of long-acting benzodiazepines. Disadvantages of a fixed approach include the cost 
associated with the increased amount of benzodiazepines utilized, an increased length of stay, and the possibility of exceeding the recommended 
benzodiazepine dosage (Finn, 2012). Individuals wanting to have elective procedures who require alcohol detoxification should be referred to 
outpatient detoxification services first. Once the detoxification is completed, scheduling of the elective procedure can occur. Although 
benzodiazepines are the treatment of choice for alcohol withdrawal (Elliot et al, 2012; Stephens et al, 2014; Weinberg et al, 2008), the associated 
risks of benzodiazepine use include patient falls, respiratory depression, aspiration pneumonia, or death (Finn, 2012). As with the CIWA-AR studies, 
benzodiazepine studies have only been conducted on detoxification units and have excluded individuals with medical comorbidities or active medical 
illness (Finn, 2012; Sarff & Gold, 2010).  
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Regardless of the approach utilized (symptom-triggered or fixed-dose) there is agreement that early patient assessment, initiation of a 
detoxification protocol, and ongoing patient assessment are critical (Elliott et al., 2012; Finn, 2012). It is often after the patient has been admitted for 
an acute medical illness on an inpatient floor that the assigned RN observes alcohol withdrawal symptoms and notifies the physician. This reactive 
approach by clinical staff often results in patients receiving increased amounts of medications to prevent further complications. The lack of a clear 
protocol and thorough initial assessment by both nurses and physicians upon entry into the healthcare system contributes to delayed initiation of the 
alcohol detoxification protocol. Our Moderate to Severe Detox Order Set is innovative because it incorporates both a fixed and a symptom-triggered 
approach based on a thorough initial risk assessment, ongoing nursing assessments, and treatment of symptoms. Support of this project will improve 
patient outcomes, reduce transfers to the ICU due to alcohol withdrawal complications, and decrease the length of stay for patients requiring alcohol 
detoxification. 
Current practice at my facility, and nationally, focuses on treating the medical condition and does not address the underlying cause or 
contributing factors of substance abuse on overall health (National Institute on Disability and Rehabilitation Research, 2010; Walsh et al., 2005).  
Treating both an acute medical illness and alcohol withdrawal simultaneously is challenging for clinicians as symptoms of the medical illness may 
mirror or mask those of alcohol withdrawal. An equivalent focus on the medical, psychiatric, and substance abuse issues with appropriate assessment, 
support, and follow up will result in improved patient outcomes, decreased length of stay, and decreased readmissions.  
Purpose 
The purpose of this capstone project is to determine if standardization of the current clinical processes and assessment tools utilized for the 
alcohol withdrawal patient population contribute to improved patient outcomes as evidenced by a reduction in the overall length of stay for the 
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substance abuse population on a non-psychiatric unit. The overarching goal of this project is to improve the quality of care and decrease the cost 
associated with treating the alcohol detoxification patient population on the non-psychiatric unit. To accomplish this, the following aims will be 
completed: The first aim is to develop a distinct clinical pathway that incorporate the nursing assessment information, BP, heart rate, and 
temperature, lab results, and significant patient history of seizures, delirium tremens, or previous ICU admissions related to alcohol detoxification in 
order to standardize the nursing and patient flow processes for the substance abuse patient population. Delirium tremens, DT’s, is a severe form of 
alcohol withdrawal that includes sudden and severe nervous system and mental changes. It occurs after an individual stops drinking after a period of 
heavy drinking and it constitutes a medical emergency. Although it can be caused by infection, illness, or head injury in those with a heavy alcohol 
use history, it is most common in individuals with a history of alcohol withdrawal and in those with an alcohol habit of greater than 10 years. 
Symptoms include decreased attention span, delirium, agitation, tactile or visual hallucinations, and generalized tonic-clonic seizures (MedlinePlus, 
2015).      
 The second aim is to develop a Moderate to Severe Detoxification Order Set. The Moderate to Severe Detoxification Order Set will standardize 
the physician’s clinical management of the patient at moderate risk for alcohol withdrawal complications. This project will indirectly address the 
issue of stigma and underestimation of use. By standardizing the clinical processes, earlier identification and targeted interventions of those at 
increased risk for alcohol withdrawal complications will result and communication between the individual and the provider regarding the risks of 
alcohol withdrawal can occur.  
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The third aim is to improve the early identification of individual level of risk for developing complications related to alcohol withdrawal, 
classification of patients into low, moderate, and severe risk, and improving the continuity of care for the substance abuse patient population by 
incorporating pharmacy, case management, and chemical dependency counselor interventions.     
Methods/Implementation 
Framework 
My PICOT (Population, Intervention, Comparison, Outcome, Time) question is Does a standardized clinical process, that includes a distinct 
clinical pathway and Moderate Detoxification Order Set, improve the clinical outcomes for individuals requiring alcohol detoxification compared to 
the current process as evidenced decrease in transfers to a higher level of care and a decreased length of stay over a twelve month period?    
The selected framework is the Theory of Symptom Management because it provides a relevant framework for care delivered to this patient 
population. 
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Figure 1. Symptom Management 
 
 
Source: Dodd, M., Janson, S., Facione, N., Faucett, J., Froelicher, E.S., Humphreys, J., … Taylor, D. (2001). Advancing the science of 
symptom management. Journal of Advanced Nursing, 33, 668-676. 
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The three main concepts of the Symptom Management Theory include symptom experience, symptom management strategies, and symptom 
status outcomes (Smith & Liehr, 2014). The Symptom Management Theory Model was revised in 2001 and 2008 to include the domains of person, 
environment, and health and illness and their influence on symptom experience, symptom management, and symptom outcomes. An example in the 
person domain includes the genetic predisposition of some individuals for developing alcohol use disorders and the likelihood of developing alcohol 
withdrawal complications (Sarf & Gold, 2010). Examples in the health and illness domain include the negative impact on the individuals’ physical 
health, medical co-morbidities, and the high correlation between alcohol use and trauma, accidents, and emergency room visits (Stephens et al, 
2005). Many examples in the environmental domain including the high recidivism rate, the lack of social supports, and the financial and legal 
stressors related to alcohol misuse overlap into multiple domains. Incorporating the influence of the domains into the model provides a more accurate 
depiction of the complexity of treating the whole person.   
Symptom experience includes vital signs, a history of alcohol withdrawal seizures, a history of delirium tremens, and a history of required 
transfer to the intensive care unit in the past related to a complicated withdrawal. Symptom management strategies include the clinical pathway and 
the Moderate Detoxification Order Set.  Symptom status outcomes will include a decrease in length of stay, a decrease need for restraint use, and a 
decrease in transfers to a higher level of care.  
Antecedent variables include RN education and attitudes, and a patient history of previous detoxification. Extraneous variables include 
socioeconomic status, supports, stigma, and culture. Moderating variables include organizational factors such as pressures to decrease length of stay, 
cost of treating the detoxification population, availability of follow up supportive services, and the quality of existing screening tools. All of these 
variables influence the quality of patient outcomes.  
16 ALCOHOL DETOXIFICATION CLINICAL PATHWAYS 
 
 
9/1/2014 
 
 
The RN assessment tool and standardized MD order set are the interventions. Early identification of patients at risk for alcohol withdrawal 
and a standardized clinical assessment, process, and order set will contribute to improved patient outcomes. Accurate and timely information will 
improve the quality of care by enabling interventions to be put in place in anticipation of the complications of alcohol withdrawal and ultimately 
improve patient outcomes and decrease costs (see Figure 2). 
  This project was submitted to the Inova Institutional Review Board (IRB) and reviewed by the Drexel IRB as well. A certificate of Exemption 
dated 4/22/1015 was obtained. The project was determined to be quality improvement with data analysis to improve internal processes and practices 
for individuals requiring alcohol detoxification services. 
  
Project 
Inclusion criteria include both male and female adults, 18 to 65 years of age, who require alcohol detoxification in the emergency department 
or on a non-psychiatric inpatient unit of the community hospital. Currently, approximately 8% of inpatients at Inova Loudoun Hospital require 
alcohol detoxification with an average length of stay of eight days. A brief patient education session about the risks associated with alcohol 
withdrawal will be incorporated into the initial emergency department nursing assessment. The admitting MD will triage the patient to the 
appropriate unit using algorithms based on presenting symptoms, labs, vital signs, and individual patient history including amount of use, duration of 
use, seizure or delirium tremens history, and previous admission to the intensive care unit for alcohol withdrawal complications. Individuals 
presenting in the emergency departments and admitted to a non-psychiatric unit will be included. Under the new standardized approach, patients 
experiencing delirium tremens in the emergency department are admitting directly to the Intensive Care Unit.  
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What began as a conversation between the Chief Nursing Officer and a medical surgical staff nurse about the challenges of managing patients 
experiencing alcohol withdrawal complications has evolved into a system-wide and multi-system process improvement initiative. A strength of the 
new standardized approach is that an interdisciplinary approach is utilized and input from hospitalists, psychiatrists, clinical nurse specialists, 
pharmacists, and informatics staff from across the system is incorporated (see Table 3). Challenges and limitations of the new program include the 
need for ongoing education of clinical staff and medical comorbidities. Medical comorbidities present a challenge to early recognition of alcohol 
withdrawal symptoms. Conditions such as delirium, pneumonia, and septicemia can have similar presentation to alcohol withdrawal symptoms 
(Elliot et al.; Finn, 2012).  
The staff education plan for nurses includes a variety of methods including online annual education, in person presentation by addictions 
specialty staff, inclusion in our annual nursing skills fair, and 1:1 coaching by our clinical nurse specialists. MD education utilizing a variety of 
algorithms to triage alcohol withdrawal patients in the emergency department will be provided to our emergency department physicians and 
hospitalists.   
Evaluation/Outcomes 
To determine the effectiveness of the new approach, a comparison of the patients treated with the new approach compared to those treated 
prior to standardization of the Clinical Institute Withdrawal Assessment for Alcohol (CIWA-Ar) and Moderate Detoxification Order Set 
implementation will be conducted to evaluate the impact of implementing a distinct clinical pathway and a combination fixed (Moderate Detox Order 
Set) and symptom-triggered (CIWA-Ar) approach.  The impact of the enhanced risk assessment will be evaluated by using historic controls, 
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specifically those who entered into alcohol withdrawal, during the 6 months prior to the May 30, 2014 implementation and comparing the rate of 
those entering into withdrawal during the 6 months after implementation. I am proposing a retrospective chart review of all patients admitted to the 
community hospital to a non-psychiatric unit for alcohol detoxification and those admitted for an acute medical illness but who require alcohol 
detoxification during hospitalization from December 2013 through November 2014.  
All patients admitted with a primary or secondary diagnosis of an alcohol use related disorder or who had a CIWA-Ar order during their stay 
will be identified by running a report in the Quality Advisor program. Monthly and quarterly aggregate data will be pulled for admission date, date 
and time of CIWA-Ar order, transfers to ICU, and discharge date and time. A Standard Product List (SPL) resource facility report will be run and ICU 
bed charge selected to calculate the percentage of detoxification patients requiring transfer to ICU.  Information obtained from Quality Advisor will 
be compared with the patient problem list in the computerized medical record. Inclusion criteria include individuals aged 18 to 65 who require 
alcohol detoxification and who have consented for voluntary admission to the hospital. Exclusion criteria include individuals admitted to the inpatient 
psychiatric unit. From this convenience sample of patients transferred to the ICU, the retrospective chart review will specifically focus on 
information about individuals who developed delirium tremens, those transferred to the intensive care unit for complications related to alcohol 
withdrawal, restraint usage, and length of stay over a twelve month period (see Table 2). In addition, the date and time of initiation of the CIWA-Ar 
protocol, compared to the patient admission date and time, is an important indicator to review as this will demonstrate whether or not we are 
identifying those at risk for alcohol withdrawal complications earlier than we had prior to the new program implementation. The pre and post 
intervention length of stay will be compared. The goal is to see a reduction in the observed/expected length of stay ratio.  
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Findings  
Initial data review from Quality Advisor was conducted using ICD-9 Codes 9461. Alcohol Rehabilitation, 9462. Alcohol Detoxification, and  
9463. Alcohol Rehabilitation and Detoxification. The 3 digit ICD-9 Codes, 291 Alcoholic Psychosis, 303 Alcohol Dependence, and 980 Alcohol 
Toxicity were selected for data abstraction. Reports were run using the 3 digit ICD-9 Codes as both a primary and secondary alcohol-related 
diagnosis for both Period 1 and Period 2. 
 
 
Although the length of stay after implementation (Period 2) was not lower as I had hoped, the observed compared to expected length of stay 
ratio for both periods was lower (3.92, 3.30; and 3.89, 3.64 respectively). The increase in the percentage of patients admitted to the ICU could reflect 
Table 1: Findings 
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better initial screening and earlier identification of those individuals most at risk for alcohol withdrawal complications and appropriate triage to ICU 
rather than to a medical floor. The average length of stay in the ICU for patients with an alcohol-related diagnosis increased from 5.1 in Period 1 to 
6.6 days in Period 2. It is difficult to draw conclusions given differences in patient population, medical comorbidities, etc. between Period 1 and 
Period 2. The most surprising and significant finding relates to mortality. The expected mortality rate in Period 1 was 3.32% (observed was 2.14%) 
and 3.15% in Period 2 (observed was 1.36%).  The actual mortality rate was .64 in Period 1 and .43 in Period 2. The observed mortality rate fell from 
2.14% in Period 1 to 1.36% in Period 2.  
Restraint data in Period 1 was eleven cases and fifteen cases in Period 2. However, given the medical comorbidities (respiratory failure, 
cardiac arrest, pulmonary embolism, trauma, and shock) it is not possible to definitively associate restraint use related to alcohol withdrawal versus a 
medical restraint secondary to other medical conditions.   
The retrospective review of 2014 ICU admissions demonstrated a significant reduction in ICU transfers from Telemetry, Medical-Surgical, 
and Post-Operative units. A total of ninety-two total cases were included in the review. See Table 2. Retrospective Review. This demonstrates an 
improved initial assessment and earlier identification of those most at risk for alcohol withdrawal complications. 
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Table 2: Retrospective Review 
 
 
 
The standardized system-wide standing order set went live on May 30, 2014, with revisions implemented on May 9, 2015, including 
pharmacy best practice advisory alerts to nurses and physicians related to total Ativan doses within twenty-four hours.  
This project will benefit our patients by preventing complications, decreasing uncomfortable withdrawal symptoms, and improving patient 
safety.  Nursing staff will benefit from the proactive, rather than reactive, interdisciplinary approach, better management of patient symptoms, and a 
decrease in patient aggression and restraint usage. The organization will benefit from a decrease in cost related to improved patient outcomes, a 
decrease in transfers to a higher level of care, and a shorter length of stay.  We hope to establish a best practice in managing patients at risk for 
alcohol withdrawal complications. Plans to disseminate information include educating clinical staff throughout the system.  
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Summary 
  
 A standardized approach to the clinical management of alcohol detoxification patients will improve the individual patient outcomes and 
decrease organizational costs associated with treating the substance abuse population. A thorough initial assessment and regular ongoing assessment 
is critical given the complexity of managing the symptoms of an acute medical illness and alcohol withdrawal symptoms simultaneously (Elliot et al.; 
Finn, 2012). Two interventions that will have the greatest impact on improving patient and organizational outcomes include a focus on the pre-
surgical assessment, primarily for elective procedures, specifically patient education about the risk of underestimating alcohol use and history and the 
potential life-threatening consequences of alcohol withdrawal and improved initial assessment of individuals requesting inpatient alcohol 
detoxification and referral when appropriate to outpatient detoxification. An individualized patient treatment course, or distinct clinical pathway, 
based on the individual patients identified risk level (high, moderate, or low) and triage to the most appropriate setting with standardized  nursing and 
MD interventions will improve the quality of care provided to patients (Elliott et al, 2012 ).     
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Appendix  
 
 
TABLE OF EVIDENCE “A DISEASE LIKE ANY OTHER”? A DECADE OF CHANGE IN PUBLIC REACTION TO SCHIZOPHRENIA, DEPRESSION, 
AND ALCOHOL DEPENDENCE 
AUTHOR/ 
YEAR 
Level of 
Evidence 
PURPOSE/ 
THEORETICAL 
FRAMEWORK 
HYPOTHESIS/ 
RESEARCH 
QUESTIONS 
DESIGN/ 
MEASURES 
SAMPLE/ 
SETTINGS 
VARIABLES  FINDINGS 
PSYCH-
METRICS 
CONCLUSIONS/ 
LIMITATIONS 
1.(Pescoso-lido, 
B., Martin, J., 
Long, J., 
Medina, T., 
Phelan, J. & 
Link, B., 2010)      
 
Level of 
Evidence = I 
 
Source of 
funding: 
 Not indicated 
Purpose: To 
assess the impact 
of presenting 
mental illness as a 
medical disease on 
adherence rates, 
stigma, and 
service use over a 
10 year period 
 
Framework:  
 
1.A 
neurobiological 
basis of mental 
illness, 
biochemical  
etiological 
theories  
 
2. View mental 
illness as diseases 
requiring medical 
Hypothesis – not 
indicated.  
 
Authors did 
mention that a 
mistaken 
assumption of 
public policy, 
clinical 
researchers, etc. 
was that public 
acceptance of a 
neurobiological 
causation of 
mental illness 
would correspond 
with a decrease in 
public stigma. 
 
 
1. Does public 
acceptance of a 
neurobiological 
Retrospective, 
cross-sectional 
longitudinal 
study 
 
1. A national 
probability 
survey of U.S. 
households was 
used. There was a 
5% difference in 
response rates 
between the two 
survey years.  
2. The survey 
utilized vignettes 
to assess the view 
of and response 
to mental illness. 
3. weighted 
adjustments were 
made to capture 
non- respondents 
 4. Used Stata, 
SAMPLE: 
1. N = 1,956 
respondents 
 
Covariates 
 
2. Gender 
 female 51% 
 
3. Age  
 43 years  
 
4. Education  
31% completed 
more than a high 
school degree 
 
5. Race  
81% Caucasian 
 
Sample consistent 
with Census 
Bureau data 
Independent 
Efforts to 
present mental 
illness as a 
medical disease 
with a neuro-
biological 
cause 
 
Dependent 
1.public in 
favor of 
treatment of 
mental illness 
by medical 
providers and 
psychiatrists 
 
2. public 
agreement of 
mental illness 
as a medical 
disease 
1. Increased 
support of a 
medical causation 
of mental illness. 
(A 6 to 13% 
increase across 
all indicators and 
all vignettes) 
 
a. schizophrenia 
increase of 10% 
 
b. major 
depression 
increase of 13% 
 
c. alcohol 
dependence 
increase of 9% 
 
2. public support 
for seeking 
treatment 
Conclusions:  
1. The change in 
public view of 
mental illness as a 
medical disease did 
not decrease the 
stigma related to 
mental illness. 
 
2. Americans’ 
perceptions of 
individuals with 
mental illness as 
dangerous lead to 
social distancing but 
does not equate to 
public support for 
federally funded 
services. 
 
Limitations: 
1. The vignette’s  
used did not directly 
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treatment, control, 
and recovery.  
 
3. Public view of 
mental illness was 
assessed. 
cause of mental 
illness increase 
treatment support 
and lessen 
stigma? 
release 11 for 
analyses 
(StataCorp, 2009) 
 
2.Recruitment 
sample survey of 
adults in U.S. 
homes 
3. Participants 
1,956 randomly 
assigned to a   
scenario that 
represented a 
psychiatric 
condition.  
4. Inclusion  
Non- 
institutionalized 
adults aged 18 
and older 
 
    Exclusion  
Institutionalized 
adults and 
homeless 
 
5. Instruments 
a. General Social 
Survey (GSS) 
 
b. face-to-face 
interviews  
 
6. Treatment 
fidelity: Trained 
 
 
  
 
 
SETTING:  
Artificial 
 
3. public view 
of people with 
mental illness 
 
4. accessing 
mental health 
services 
 
5. treatment 
compliance 
rates 
increased (from 
75% to 
85%;F=9.27, 
p=0.002) 
 
3. Stigma did not 
decrease for any 
of the variables 
tested. Actually, 
stigma increased 
for two of the 
questions:  
a. 11% less 
willing to have a  
schizophrenic 
neighbor  
b. 9% less 
supportive of an 
in-law with 
alcohol 
dependence   
4.  given 
weighted data, 
used design-
based F statistic 
(StataCorp, 2009 
5. discrete change 
coefficients with 
controls were 
used for the 
combined sample 
 
6. The discrete 
change 
coefficients and 
test  recovery and 
stigma  
 
2.attitudes may or 
may not lead to 
behaviors 
(discrimination) 
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interviewers held 
face-to-face 
interviews 
  
7. data collection, 
paper and pencil 
in 1996 and 
computer-
assisted 2006  
 
predicted 
probabilities were 
multiplied by 
100. 
 
7. gender, age, 
education, and 
race had no 
significant effect  
 
 
 
 
TABLE OF EVIDENCE THE STIGMA OF PSYCHIATRIC DISORDERS AND THE GENDER, ETHNICITY, AND EDUCATION OF THE PERCEIVER 
AUTHOR/Y
EAR 
Level of 
Evidence 
PURPOSE/ 
THEORETICAL 
FRAMEWORK 
HYPOTHESIS/ 
RESEARCH 
QUESTIONS 
DESIGN/ 
MEASURES 
SAMPLE/ 
SETTINGS 
VARIABLES  FINDINGS 
PSYCHO 
METRICS 
CONCLUSIONS/ 
LIMITATIONS 
1.(Corrigan, 
P.& Watson, 
A., 2007) 
 
 
 
Level of 
Evidence =  
II 
 
 
 
 
 
 
Purpose: To 
determine if 
individual 
demographics 
influence how they 
primary, courtesy, 
and public stigma 
 
 
 
Framework:  
Not indicated 
1. Males endorse 
stigma more than 
females. 
 
2. Higher 
education results 
in more tolerance 
of mental illness. 
 
3. White 
participants more 
likely to endorse 
stigma 
 
Do gender, race, 
and education 
National 
population-
based studies, 
randomly 
assigned 
vignettes  
 
1. Participants 
Family Stigma 
Data Survey, 
N=968 
2.Recruitment 
Knowledge 
Networks -U.S. 
telephone 
population, 
SAMPLE: 
 
1.Participants 
N=968  
 
2. Gender 
51.9% female 
 
3. Age  
Mean age = 47 
years (SD = 16.5, 
range =18-95) 
 
4. Education  
(a proxy of 
familiarity with 
Independent 
1.Gender 
 
2.Ethnicity 
   Race 
  
3. Education 
 
 
 
 
 
 
 
 
1.Hypothesis  
1 & 2 were 
accepted 
Hypothesis 3 was 
not. 
 
2. Males 
endorsed stigma 
more than 
females. 
 
3. The more 
educated the 
perceiver, the less 
likely to 
stigmatize.  
Conclusions:  
 
1. A study of stigma 
must include cultural 
considerations.  
 
 
 
 
 
 
 
 
Limitations: 
1.sample recruited 
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Source of 
funding:  
Not indicated 
level affect a 
person’s attitudes 
and behaviors 
towards people 
with mental 
illness? 
oversampled 
households with 
pre-existing 
home-based 
internet access.  
3. Participants  
Randomly 
identified and 
solicited 
4. Inclusion  
Randomly 
selected from 
those who had a 
telephone 
   Exclusion  
 none    
5. Instruments 
a. national 
sample  
b. randomly 
assigned vignette  
c. focus groups 
d. An attributions 
questionnaire was 
used. 
 
mental illness) 
Completed high 
school = 15.8% 
High school 
graduates = 32.1% 
Some college = 
27.8% 
Bachelor’s or 
higher = 24.4% 
 
5. Race  
White = 72.5% 
Black = 11.7% 
Hispanic = 11% 
Other = 4.8% 
  
SETTING:  
Artificial – 
national survey, 
questionnaires 
Dependent 
1.stigma 
 
 
4. A surprise 
finding was that 
Caucasians 
endorsed stigma 
less than other 
ethnic groups.  
 
5. To ensure 
sample 
demographics 
aligned with 
2000 U.S. census, 
post-survey 
stratification 
weights used  
 
6. Stratification 
weight variables 
included: age, 
race, gender, 
ethnicity, level of 
education, and 
geographic 
region of the U.S. 
through random digit 
dialing 
 
2.ethnicity limited to 
white and nonwhite 
 
3.instruments 
included only 
attitudes and 
behavioral intentions 
 
 
 
 
 
 
TABLE OF EVIDENCE PERCEIVED BARRIERS AND FACILITATORS TO MENTAL HEALTH HELP-SEEKING IN YOUNG PEOPLE: A 
SYSTEMATIC REVIEW 
AUTHOR/
YEAR 
Level of 
Evidence 
PURPOSE/ 
THEORETICAL 
FRAMEWORK 
HYPOTHESIS/ 
RESEARCH 
QUESTIONS 
DESIGN/ 
MEASURES 
SAMPLE/ 
SETTINGS 
VARIABLES  FINDINGS/ 
PSYCHO-
METRICS 
CONCLUSIONS/ 
LIMITATIONS 
1.(Gulliver, Purpose: Hypothesis – not Systematic SAMPLE: Independent 1. Main barriers Conclusions:  
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A., 
Griffiths, 
K., & 
Christensen
, H., 2010)     
 
Level of 
Evidence = 
I 
 
Source of 
funding: 
grant from 
the 
Australian 
Institute of 
Sport 
(AIS), 
Amelia 
Gulliver is 
supported 
by a joint 
scholarship 
from the 
AIS, the 
Brain and 
Mind 
Research 
Institute, 
Orygen, 
and The 
Australian 
National 
University. 
Professor 
To identify reasons 
adolescents and young 
adults do not use 
mental health services 
and to identify factors 
that promote service 
use 
 
Framework:  
Thematic analysis 
conducted on 
qualitative studies.  
 
Quantitative studies 
tabulated and top rated 
themes extracted. 
 
Fifteen studies were 
qualitative. 
Interviews, focus 
groups, and surveys 
were used.  
 
 
Seven studies were 
quantitative and used 
survey method to 
collect data. 
indicated.  
 
 
1. What are the 
main barriers to 
help seeking for 
mental health 
services in 
adolescents and 
young adults?  
 
 
 
2. What are the 
main facilitators 
to help seeking 
for mental health 
services in 
adolescents and 
young adults?  
 
 
 
review, 
retrospective 
surveys, focus 
groups, and 
interviews, and 
quantitative 
data from 
published 
surveys 
1.Studies 
conducted in 
Australia, the 
United States, the 
United Kingdom, 
and China and 
published 
between 1990 
and 2008  
 
2. Recruitment 
3,637 records 
identified from 
database  
3. Participants 
 Adolescents and 
young adults   
 
4. Inclusion 
22 studies 
included in the 
qualitative 
synthesis 
   Exclusion 
32 records 
removed –
1.Participants  
Varied from 3 to 
3,746 
a. Most of the 
qualitative  
Studies included 3 - 
52 participants. 
 
Three additional 
studies included 
326 - 3,746 
participants. 
b. The 7 
quantitative studies 
ranged from 71 -
294 participants. 
  
2. Gender 
a. 19 of the studies 
included both male 
and female. 
 
b. 2 studies 
included male only 
c. 1 study female 
only 
 
3. Age  
Data reported for 
young adults 
varied.  
 
SETTING:  
Artificial due to 
published survey 
1.stigma 
2.embarrass-
ment 
3.mental health 
literacy 
4.self-reliance 
5.past 
experience with 
mental health 
6.social support 
 
 
 
 
Dependent 
1.help seeking 
for mental 
health services 
 
 
  
 
  
to seeking 
treatment in 
young adults 
include:  
a. stigma   
b. embarrassment 
c. not recognizing 
symptoms 
d. prefer to be 
self-reliant 
 
2. Factors that 
promote help 
seeking include a 
positive past 
experience with 
providers and 
treatment,  social 
support and 
encouragement 
  
 
 
 
To 
Increase adolescents 
and young adults use 
of treatment, 
interventions should 
focus on decreasing 
stigma, improving 
their knowledge of 
mental health 
symptoms, and 
promoting self-
reliance in their 
decision to seek 
care. 
Limitations: 
1.search strategy 
may not have 
included all relevant 
articles 
 
2.only three 
databases were 
utilized 
 
3. Search 
terminology may 
have limited the 
relevant research 
results on 
encouragers and 
dissuaders of 
treatment 
 
4.only published 
literature was 
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Griffiths is 
supported 
by an 
NHMRC 
Fellowship 
No. 525413 
and 
Professor 
Christensen 
by 
NHMRC 
Fellowship 
No. 
525411. 
duplicates 
3,669 records 
screened. 3,377 
records excluded. 
Of the remaining 
292 records, 
270 excluded due 
to: did not 
address barriers 
or facilitators, not 
for depression or 
anxiety, not aged 
12-25, study was 
a review, not 
from community, 
parent caregiver, 
data not 
extractable, and 
study involved 
mental health 
condition other 
than depression, 
anxiety, or 
general “mental 
distress”. N=22 
5. Instruments 
a. surveys 
b. focus groups 
c. interviews 
6. Treatment 
fidelity: See 
limitation #5 
data. Natural due 
to focus groups 
and interviews. 
a.11 studies 
conducted in high 
school setting 
b. 5 studies in 
universities (2 of 
the 5 examined 
medical students 
& 1 rural 
psychology 
undergraduates) 
c. 5 in community 
setting (1 
examined at- risk 
African American 
male adolescents 
and 1 rural 
adolescents) 
d. 1 high school 
and community 
setting  
e 3 rural studies 
conducted 
sourced  
 
5.only one 
researcher coded 
themes 
  
6. qualitative 
research is a 
subjective process 
 
7. The review was 
done differently in 
the qualitative and 
quantitative. Counts 
of themes and 
studies including the 
themes were 
included in the 
qualitative. 
However, the 
quantitative included 
only the highest 
rated theme.  
 
 
TABLE OF EVIDENCE NEGATIVE ATTITUDES TOWARD HELP SEEKING FOR MENTAL ILLNESS IN 2 POPULATION-BASED SURVEYS FROM 
THE UNITED STATES AND CANADA 
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AUTHOR/ 
YEAR 
Level of 
Evidence 
PURPOSE/ 
THEORETICAL 
FRAMEWORK 
HYPOTHESIS/ 
RESEARCH 
QUESTIONS 
DESIGN/ 
MEASURES 
SAMPLE/ 
SETTINGS 
VARIABLES  FINDINGS/ 
PSYCHO-
METRICS 
CONCLUSIONS/ 
LIMITATIONS 
1.(Jagdeo, 
A., Cox, B., 
Stein, M.,& 
Sereen, J., 
2009)     
 
Level of 
Evidence = 
I  
 
 
 
Source of 
funding:  
Canadian 
Institutes of 
Health 
Research 
Grant, NIH 
Award,  
 
 
Purpose: To explore 
the relation between 
socio-demographics 
and  attitudes toward 
help seeking for 
mental illness among 
the public in the U.S. 
and Ontario.  
 
To identify the 
demographics of 
those least likely to 
seek care (negative 
attitudes toward 
treatment) so that 
targeted education 
can be developed 
 
Framework:  
“Anderson’s 
behavioral model of 
health service use. 
Predisposing 
characteristics, 
enabling resources, 
and perceived and 
actual need, 
determine the use of 
health services. A key 
element in the model 
is the person’s 
Hypothesis was 
not specifically 
stated. 
 
 
 
 
1.How common 
is resistence to 
treatment in the 
U.S. and Canada?  
 
2. Do particular 
socio-
demographic 
groups, and 
mental disorder,  
correlates with 
negative attitudes 
toward seeking 
care? 
 
Two population 
based cross-
sectional surveys 
were analyzed  
 
1.Data  
Obtained from 
Canadian and  
U.S. national 
surveys (Total 
sample 8,098) 
Response rate 
82.4% 
 
2.Recruitment 
Only participants 
who completed 
Part II of the 
Ontario Health 
Survey (OHS) 
were included 
3. Participants  
14,758 
households, of 
these 13, 002 
participated in 
Part II of OHS       
4. Inclusion 
5,877 included 
who were asked 
questions about 
SAMPLE: 
1.Participants 
5,877 from the 
NCS 
6,902 from the 
OHS  
2. Gender  
Male, Female 
3. Age  
a. 15 -24 years 
b. 25-34 years 
c. 35-54 years 
 
4. Education  
a. 12 years and less 
b. > than 12 years 
 
5. Income 
Employment 
status 
a. low 
b. low to average 
c. average to high 
d. high 
 
6. Marital Status 
a. single or never 
married 
b. separated, 
divorced or 
widowed 
Independent 
1. Age 
2. Sex 
3. Marital 
status 
4. Education 
5. Income 
6. Health 
insurance 
(NCS) 
 
 
 
Dependent 
1. Views on 
obtaining 
treatment in 
Canada and the 
United States 
 
1. Negative 
attitudes toward 
treatment 
correlated with 
treatment drop- 
out rates. 
 
2. Multiple 
logistic 
regression 
analyses used to 
examined the 
themes of  
Comfort, 
probability, and 
embarrassment.  
3. A composite 
score variable 
(attitude) was 
determined.  
 
4. Survey data 
analyses was 
performed. 
 
5.  A composite 
variable was 
used. 
Conclusions:  
1. Both the U.S. and 
Ontario respondents  
have negative 
attitudes toward 
mental health 
services. 
 
2. Negative attitudes 
found in young 
adults less educated, 
with less 
socioeconomic 
resources, with any 
lifetime mental 
disorder 
 
3. Unmarried  
females were 
supportive of 
treatment. 
 
Limitations 
1. Mental disorders 
were assessed during 
the interview by 
non-clinicians. 
2. Data collected in 
the 1990’s. Attitudes 
change over time. 
3. The measurement 
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attitude toward 
mental health 
treatment” 
(Anderson, R.M., 
1995)  
service use  
 
Mental Health 
Supplement 
9,953 
respondents 
(67.4% response 
rate) 6,902 
participants 
included 
    Exclusion 
2,221 excluded 
due to not asked 
questions about 
service use 
 
People age < 15 
and  
> age 54 
 
5. Instruments 
a. 2 population-
based surveys  
b. weighted 
adjustments used.   
6. Treatment 
fidelity: data 
collected by 
trained people 
who conducted 
interviewers from 
a probability 
sample.  
c. married or 
common law  
7. Health 
insurance 
a. none 
b. Medicaid  
c. health insurance 
–not Medicaid 
 
SETTING: 
Artificial- 
national surveys 
of attitudes was not 
detailed.  
4. The Canadian 
Community Health 
Survey: Mental 
Health and Well-
being did not have 
questions regarding 
treatment attitudes. 
Therefore, could not 
compare to U.S. 
responses.   
 
5. Longitudinal data 
is not available on 
the long term 
benefits of mental 
health treatment.  
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TABLE OF EVIDENCE PREJUDICE, SOCIAL DISTANCE, AND FAMILIARITY WITH MENTAL ILLNESS 
AUTHOR/ 
YEAR 
Level of 
Evidence 
PURPOSE/ 
THEORETICAL 
FRAMEWORK 
HYPOTHESIS/ 
RESEARCH 
QUESTIONS 
DESIGN/ 
MEASURES 
SAMPLE/ 
SETTINGS 
VARIABLES  FINDINGS/ 
PSYCHO-
METRICS 
CONCLUSION
S/ 
LIMITATIONS 
1.(Corrigan, 
P., Edwards, 
A., Green, 
A., Diwan, S. 
& Penn, D., 
2001)  
 
Level of 
Evidence = 
II 
 
Source of 
funding: not 
indicated 
Purpose: 
To improve 
understanding of 
mental illness 
stigma and 
determine if 
prejudicial 
attitudes, being 
familiar with 
mental illness, 
and race impact 
social distancing.  
 
Framework: 
Experience with 
the mental illness 
population and 
ethnicity 
influence 
prejudicial 
attitudes 
(benevolence and 
1. Familiarity 
with mental 
illness and 
ethnic 
background 
impact 
prejudicial 
attitudes 
toward mental 
illness 
 
2. Prejudicial 
attitudes 
toward mental 
illness lead to 
social 
distancing.  
 
1. Recruitment 
24 community 
colleges students  
2. Participants  
240 students 
3. Inclusion  
151 participants 
that provided 
data sets 
Exclusion  
89 subjects did 
not complete the 
study 
requirements 
4. Instruments 
To determine 
how participants 
ranked mental 
illness, 3 tools 
were utilized:  
a. The Level of 
Contact Report 
SAMPLE: 
Convenience 
sample, voluntary 
participants from 
community 
colleges 
1.151 Patients 
  
2. Gender 
 81.9% female 
18.1% male 
 
3. Age  
mean 37.9 
 
4. Education 
83.6% of 
participants had 
some college 
 
5. Race   
77.9% White, 
Independent 
1. Benevolent 
attitudes 
2. 
Authoritarian 
attitudes 
3. Familiarity 
with mental 
illness 
4. Ethnicity 
 
Dependent 
1. social 
distancing 
 
Social distance 
was the proxy 
measure of 
behavioral 
discrimination 
 
Looked at the 
1. Little 
correlation 
between 
familiarity and 
ethnicity. 
2. Both forms of 
prejudice, 
authoritarian & 
benevolent 
attitudes lead to 
social distancing.  
3. The path 
coefficient for 
benevolence and 
social distance (-
0.40) and (0.24) 
for 
Authoritarianism 
and social 
distance.  
4. Both 
hypotheses were 
Conclusions:  
Benevolence is 
a stronger 
predictor of 
social distance 
than 
authoritarian-
ism 
 
Familiarity and 
ethnicity does 
influence 
benevolent and 
authoritarian 
attitudes  
 
Limitations: 
1. Small sample 
size (151) 
2. Participants 
included 81.9% 
female, 77.9% 
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authoritarianism) 
towards those 
with mental 
illness  
 
Benevolence and 
authoritarianism 
leads to social 
distancing   
(Holmes et al. 
1999) to test 
familiarity  
 
b. the OMI 
questionnaire 
(Cohen and 
Struening,   
1962) to test 
authoritarian and 
benevolent 
attitudes 
 
c. the Social 
Distance Scale 
(Link et al 1987; 
Penn et al 1994) 
to test social 
distance 
 
22.1% nonwhite  
  
6. SETTING   
Artificial – all 
participants 
participating in a 
statewide para-
professional 
training 
effects of two 
person 
variables – 
familiarity 
with mental 
illness and 
ethnicity on 
prejudice 
accepted.  
5. Both 
benevolent and 
authoritarian 
attitudes lead to 
social distancing.   
5. Chi square to 
test goodness to 
fit found that the 
model fit the data 
6. Path analysis 
was used to 
examine the size 
and direction 
among the  
variables 
(race/ethnicity, 
authoritarian and 
benevolent 
attitudes, and 
familiarity) to 
determine the 
most important 
predictors of 
social distancing 
 
 
white, & 83.6% 
some college 
education. A 
threat to 
external validity 
exists. 
3. Only 20% 
male 
participants 
4. The % of 
actual 
participants who 
worked in the 
mental health 
field was not 
disclosed 
5. Need further 
research of 
prejudice and 
social distance 
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TABLE OF EVIDENCE EMBARRASSMENT WHEN ILLNESS STRIKES A CLOSE RELATIVE: A WORLD MENTAL HEALTH SURVEY 
CONSORTIUM MULTI-SITE STUDY 
AUTHOR/Y
EAR 
Level of 
Evidence 
PURPOSE/ 
THEORETICAL 
FRAMEWORK 
HYPOTHESIS/ 
RESEARCH 
QUESTIONS 
DESIGN/ 
MEASURES 
SAMPLE/ 
SETTINGS 
VARIABLES  FINDINGS  
PSYCHO-
METRICS 
       
CONCLUSION
S/ 
LIMITATIONS 
1.(Ahmedani, 
B.K., 
Kubiak, S.P., 
Kessler, 
R.C., 
deGraaf, R. 
& Alonso, J., 
2013)     
 
Level of 
Evidence = I 
 
Source of 
funding: 
Purpose: To 
assess ‘family 
embarrassment’ 
as a form of 
social stigma  
 
In addition, 
comparison of 
embarrassment 
related to an 
alcohol, drug, or 
mental health 
condition 
(ADMC) 
The hypothesis 
is that the group 
with both an 
ADMC and 
GMC would 
result in greater 
embarrass-ment 
for the family 
 
Standardized 
assessments in 
16 sites. 
1.Recruitment 
Total WMHS 
sample from 23 
countries 
n=118,177 
3. Participants  
16 WMHS sites 
included in the 
study   
4. Inclusion 
81,144 
SAMPLE: 
samples drawn 
from, recruited, 
and assessed 
from 16 different 
sites of the 
World Mental 
Health Surveys 
(WMHS) 
 
1. n = 81,144  
 
2. Sites included 
Africa, the 
Independent 
Close relative 
with an ADMC 
 
Close relative 
with a GMC 
 
Close relative 
with both an 
ADMC and a 
GMC 
 
Family burden 
 
1. Family 
embarrassment 
occurred more 
often when close 
relative has an 
alcohol, drug, or 
mental health 
condition 
(ADMC) 
compared to a 
general medical 
condition (GMC) 
(OR 1.7, 
p<0.001) 
Conclusions:  
Stigma-laden 
feelings 
(family 
embarrassment
) occur more 
often when a 
close relative 
has an ADMC 
compared to a 
GMC 
 
Limitations: 
1. Focus on 
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NIH Grants, 
John & 
Catherine 
MacAthur 
Foundation, 
Pfizer 
Foundation,  
(29 
additional 
sources of 
funding) 
compared to a 
general medical 
condition (GMC) 
or both an ADMC 
and GMC. 
Framework: 
Survey 
administered in 2 
parts face-to-face 
by a staff member 
or via computer-
assisted interview 
respondents  
 Exclusion  
37,000 
incomplete data 
and 47,116 were 
excluded due to  
not answering 
Part II questions 
 
5. Instruments 
a. Site matching 
and a conditional 
logistic 
regression model 
were used to  
estimate family 
embarrassment 
experienced 
 
 
Americas, Asia, 
and Europe 
 
Setting 
Artificial due to 
World Mental 
Health Surveys  
 
  
Dependent 
1. Family 
embarrass-ment 
 
 
  
including after 
covariant 
adjustments for 
age and sex. 
 
2. An ADMC is 
viewed more 
negatively than a 
GMC 
 
3. 11.7% (n=460) 
embarrassed a lot, 
11.7% (n=458) 
embarrassed 
some, and 9.6% 
(n=377) 
embarrassed a 
little 
 
4. 24.9% of 
relatives with a 
GMC only felt 
embarrassed, 
compared to 
49.5% in the 
ADMC only 
group, and 36.6% 
in the GMC+ 
ADMC group 
 
 
‘family 
embarrass-
ment’ facet of 
stigma only, 
did not include 
other facets of 
stigma 
2. Stigmatized 
GMCs such as 
epilepsy were 
not mentioned 
in the WMHS 
3. Stigma 
questions were 
addressed in 
Part II only, 
smaller 
subsample size. 
4. Language 
variations may 
be responsible 
for site 
variations 
observed. 
5. ‘fixed 
effects’ 
approach does 
not allow 
analysis 
weights 
6. Part II 
sample size too 
small to allow 
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for pre-planned 
analysis and 
individual 
country 
estimates 
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TABLE OF EVIDENCE EMERGENCY DEPARTMENT SERVICES FOR PATIENTS WITH ALCOHOL PROBLEMS: RESEARCH 
DIRECTIONS 
RESEARCH  
 
REVIEW 
 
NEITHER 
AUTHOR/ 
YEAR 
 
PURPOSE 
  
TYPE OF 
STUDY  
 
KEY 
DEFINITIONS  
 
CREDIBILITY 
SETTING  
 
REVIEW 
BOUNDARIES  
 
 
QUALITY 
DATA 
COLLECTION 
METHODS 
APPRAISAL 
CRITERIA  
 
CONTENT 
MAJOR 
FINDINGS  
 
SYNTHESIS OF 
STUDIES  
 
COHERENCE 
RECOMMEND
ATIONS  
 
SUMMARY/ 
CONCLUSION 
 
Review 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Hungerford & 
Pollack, 2003 
 
 
 
 
 
1. To 
summarize 
research 
recommendatio
ns for 
identification 
and 
interventions 
for patients 
with alcohol 
problems in 
emergency 
department. 
 
 
 
  
Alcohol 
problems – term 
to encompass the 
range of chronic 
alcohol problems 
as well as the 
acute, 
intermittent, and 
mild-to-
moderate 
problems 
associated with 
alcohol use. 
 Review of 
impact of alcohol 
problems, 
emergency 
department scope 
of practice, 
suggested 
interventions for 
ED patients with 
alcohol problems, 
implementation 
of preventive 
interventions in 
the emergency 
department 
Conference of 
64 experts in 
the field 
including 
clinicians and 
researchers 
from trauma 
surgery and 
emergency 
medicine, 
psychologists, 
psychiatrists, 
epidemiologist
s, & alcohol 
researchers.  
Synthesis from 
the conference 
Alcohol-related 
problem research 
in ED patients, 
ED-based 
intervention 
studies, how to 
operationalize 
proposed 
screening 
methods in the 
ED & referrals 
for alcohol 
treatment, 
research on the 
effect of public 
and private policy 
on patient 
confidentiality, 
cultural and 
demographic 
factors impact on 
Funding for the 
seven research 
recommendatio
ns is justified 
because alcohol 
problems utilize 
a large 
percentage of 
emergency 
department 
resources 
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access to care & 
patient outcomes, 
clinical 
guidelines, policy 
& practice impact 
on ability to 
screen and 
intervene, role of 
IT in facilitating 
alcohol treatment, 
increased 
involvement of 
ED physicians 
and RNs in 
research and 
increased funding 
for research 
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TABLE OF EVIDENCE AN ALCOHOL FOCUSED INTERVENTION VERSUS A HEALTHY LIVING INTERVENTION 
 
RESEARCH  
 
REVIEW 
 
NEITHER 
AUTHOR/ 
YEAR 
 
PURPOSE 
  
TYPE OF 
STUDY  
 
KEY 
DEFINITIONS  
 
CREDIBILITY 
SETTING  
 
REVIEW 
BOUNDARIES  
 
 
QUALITY 
DATA 
COLLECTION 
METHODS 
APPRAISAL 
CRITERIA  
 
CONTENT 
MAJOR 
FINDINGS  
 
SYNTHESIS OF 
STUDIES  
 
COHERENCE 
RECOMMEND
ATIONS  
 
SUMMARY/ 
CONCLUSION 
 
Research 
 
 
 
  
 
 
 
 
 
 
Watson et al. 
Trials, 2013 
 
 
 
 
To evaluate 
effectiveness 
of 2 different 
interventions, 
an alcohol-
focused and a 
healthy- living 
focused  
 
 
 
  
Randomized, 
open, controlled 
pilot trial 
 UK general 
hospital setting 
Participants 
recruited and 
qualitative 
interviews 
being 
conducted 
In progress 
 
pending 
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TABLE OF EVIDENCE MANAGING ALCOHOL WITHDRAWAL IN HOSPITALIZED PATIENTS 
RESEARCH  
 
REVIEW 
 
NEITHER 
AUTHOR/ 
YEAR 
 
PURPOSE 
  
TYPE OF 
STUDY  
 
KEY 
DEFINITIONS  
 
CREDIBILITY 
SETTING  
 
REVIEW 
BOUNDARIES  
 
 
QUALITY 
DATA 
COLLECTION 
METHODS 
APPRAISAL 
CRITERIA  
 
CONTENT 
MAJOR 
FINDINGS  
 
SYNTHESIS OF 
STUDIES  
 
COHERENCE 
RECOMMEND
ATIONS  
 
SUMMARY/ 
CONCLUSION 
 
Neither 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Elliott, D., Geyer, 
C., Lionetti, T., & 
Doty, L., 2012 
 
 
 
To educate 
nurses on how 
to conduct a 
focused patient 
assessment to 
identify those 
at risk for 
alcohol 
withdrawal 
symptoms and 
develop 
nursing 
interventions, 
To review 
various 
assessment 
tools and 
medication 
management of 
alcohol 
withdrawal 
symptoms   
 
  
Alcohol 
dependence- 
craving, loss of 
control, physical 
dependence and 
tolerance. 
 
Alcohol 
Withdrawal 
Syndrome 
(AWS) – 
collective signs 
and symptoms 
associated with 
alcohol cessation 
including chills, 
cravings, 
anorexia, 
disorientation, 
tachycardia, 
hypertension, 
low grade fever, 
mood changes, 
impaired gait, 
abdominal pain 
Clinical Nurse 
Specialist from 
NIH  
Review of 
AWS signs and 
symptoms, 
timing of onset 
of symptoms, 
review of 
assessment 
tools, role of 
benzodiazepine
s in managing 
symptoms, 
review of DT’s 
and 
recommended 
nursing 
interventions  
Well organized 
began with 
prevalence, 
overview of signs 
and symptoms, 
reviewed 
assessment tools, 
explained the 
pathophysiology 
and ended with 
recommended 
nursing 
interventions for 
the hospitalized 
patient  
A focused 
nursing risk 
assessment is 
crucial to 
identify and 
implement 
nursing 
interventions for 
those at risk for 
alcohol 
withdrawal 
complications 
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TABLE OF EVIDENCE INPATIENT MANAGEMENT OF ALCOHOL WITHDRAWAL 
RESEARCH  
 
 
REVIEW 
 
NEITHER 
AUTHOR/ 
YEAR 
 
PURPOSE 
  
TYPE OF 
STUDY  
 
KEY 
DEFINITIONS  
 
CREDIBILITY 
SETTING  
 
REVIEW 
BOUNDARIES  
 
 
QUALITY 
DATA 
COLLECTION 
METHODS 
APPRAISAL 
CRITERIA  
 
CONTENT 
MAJOR 
FINDINGS  
 
SYNTHESIS OF 
STUDIES  
 
COHERENCE 
RECOMMEND
ATIONS  
 
SUMMARY/ 
CONCLUSION 
 
 
Review 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Finn, K., 2012 
 
 
To review the 
current 
assessment 
tools and 
medication 
management of 
alcohol 
withdrawal in 
inpatient 
hospitalized 
patients 
 
 
  
DSM-IV-TR 
defines  
Alcohol Abuse 
(1 or more 
criteria for >1 
year as) a failure 
to fulfill work or 
home 
obligations, 
intoxification 
while driving or 
other risky 
behavior, legal, 
social, or 
personal 
problems related 
to alcohol use.  
 
DSM-IV-TR 
defines  
 Alcohol 
dependence as (3 
criteria over > 1 
year) as 
increased 
Included 52 
references 
ranging from 
1953 – 2011 
 Author notes 
that all of the 
studies on 
DT’s are older, 
published 
between the 
1960’s and 
1970’s.  
Treatment of 
Alcohol 
withdrawal 
 
Review of 
assessment tools 
Management of 
DT’s and seizures 
Initial and 
frequent patient 
assessment of 
those at risk for 
alcohol 
withdrawal is 
crucial, use only 
single 
benzodiazepine, 
consider 
comorbidities - 
recognize that 
symptoms may 
result from 
alcohol 
withdrawal or 
the acute illness, 
CIWA-AR has 
not been 
validated in use 
with patients 
hospitalized for 
a different acute 
medical illness, 
taper 
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tolerance to 
alcohol, alcohol 
withdrawal, 
drink more than 
intended, 
ongoing desire to 
cut down, 
excessive time 
obtaining or 
recovering from 
effects of, 
impaired social 
and or work, 
ongoing use 
despite physical 
or psychological 
problems  
 
CIWA-AR - a 
10-item scale 
with each item 
rated on a 7-
point scale, with 
the exception of 
orientation, 
which is rated on 
a 4-point scale. 
The most widely 
utilized scale, 
however has not 
been validated in 
patients with 
medical 
benzodiazepines 
after 48-72 
hours 
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comorbidities. 
 
 
TABLE OF EVIDENCE CROSSED EVALUATIONS OF TEMPTATION TO DRINK, STRAIN, AND ADJUSTMENT IN COUPLES WITH 
ALCOHOL PROBLEMS 
RESEARCH  
 
REVIEW 
 
NEITHER 
AUTHOR/ 
YEAR 
 
PURPOSE 
  
TYPE OF 
STUDY  
 
KEY 
DEFINITIONS  
 
CREDIBILITY 
SETTING  
 
REVIEW 
BOUNDARIES  
 
 
QUALITY 
DATA 
COLLECTION 
METHODS 
APPRAISAL 
CRITERIA  
 
CONTENT 
 
 
MAJOR 
FINDINGS  
 
SYNTHESIS OF 
STUDIES  
 
COHERENCE 
RECOMMEND
ATIONS  
 
SUMMARY/ 
CONCLUSION 
 
 
 Research 
 
 
 
 
 
 
 
 
 
 
 
 
 
Antoine P., 
Christophe V., & 
Nandrino J.,  
2009 
 
 
 To describe 
the descrepan-
cies between 
patient and 
spouse dyadic 
adjustment 
scores, spouse 
strain, nd 
patient 
temptation to 
drink during 
abstinence 
 
 
Cross evaluation 
of strain, dyadic 
adjustment and 
alcohol problems 
in patients and 
spouses. Alcohol 
problem 
evaluations 
independently 
measured using 
objective and 
subjective 
measures. 
Sample = 66 
problem drinkers 
and 66 spouses 
  
Patients were 
recruited 
following 
inpatient 
treatment for 
alcohol problems. 
Consent obtained.  
Drinking 
frequency and 
quantity were 
measured. The 
Short Michigan 
Alcohol 
Screening Test 
– 13 item 
questionnaire, 
the Alcohol 
Abstinence 
Self-Efficacy 
Scale – 20 item 
scale, the 
Revised Dyadic 
Adjustment 
Scale- 16 item, 
& The 
Caregiver 
Reaction 
 
Divergence can 
result from 
spouse 
overstatement of 
drinking risk & 
minimalization 
of patient self-
efficacy. 
Divergence can 
occur as result of 
patient 
minimization of 
the problem 
 
Behavioral 
reactions and 
coping depend 
on each 
partners’ 
perception of 
the problem, 
encourage 
healthy 
communication 
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Assessment -24 
item  
 
 
TABLE OF EVIDENCE: THE IMPACT OF SCREENING, BRIEF INTERVENTION, AND REFERRAL FOR TREATMENT IN 
EMERGENCY DEPARTMENT PATIENTS’ ALCOHOL USE: A 3, 6, AND 12 MONTH FOLLOW UP  
RESEARCH  
 
REVIEW 
 
NEITHER 
AUTHOR/ 
YEAR 
 
PURPOSE 
  
TYPE OF 
STUDY  
 
KEY 
DEFINITIONS  
 
CREDIBILITY 
SETTING  
 
REVIEW 
BOUNDARIES  
 
 
QUALITY 
DATA 
COLLECTION 
METHODS 
APPRAISAL 
CRITERIA  
 
CONTENT 
MAJOR 
FINDINGS  
 
SYNTHESIS OF 
STUDIES  
 
COHERENCE 
RECOMMEND
ATIONS  
 
SUMMARY/ 
CONCLUSION 
 
 
Research 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Aseltine, R., 2010 
 
 
 
To determine 
the impact of 
Screening, 
Brief 
Intervention, 
and referral for 
treatment 
(SBIRT) in 
reducing 
alcohol 
consumption in 
ED patients at 
3, 6, and 12 
months 
following the 
intervention. 
  
Quasi-
experimental 
comparison 
group design. 
Patients drinking 
at low-risk levels 
were recruited 
from 14 sites 
across the US. 
Sequential 
recruitment of 
intervention and 
control patients. 
Control group 
received written 
handout. 
Intervention 
group – handout, 
brief interview, 
and referral to tx. 
 
  
Emergency 
Department 
 
1132 eligible 
& enrolled, 
63%, 52%, and 
38% 
completed 
follow up 
surveys at 3, 6, 
and 12 months. 
Regression 
analysis 
 
Those receiving 
SBIRT reported 3 
less drinks per 
week than 
controls & 
maximum drinks 
per occasion was 
¾ of a drink less 
than controls at 3 
months. At 6 and 
12 months results 
no longer 
statistically 
significant.  
 
 
 
SBIRT is 
effective in the 
short term in 
reducing at-risk 
drinking. 
Increased 
contact and 
booster 
programs may 
be required for 
long-term 
reduction of 
risky drinking.  
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Follow up 
surveys via 
telephone.  
 
 
TABLE OF EVIDENCE: ALCOHOL WITHDRAWAL SYNDROMES IN THE INTENSIVE CARE UNIT  
RESEARCH  
 
REVIEW 
 
NEITHER 
AUTHOR/ 
YEAR 
 
PURPOSE 
  
TYPE OF 
STUDY  
 
KEY 
DEFINITIONS  
 
CREDIBILITY 
SETTING  
 
REVIEW 
BOUNDARIES  
 
 
QUALITY 
DATA 
COLLECTION 
METHODS 
APPRAISAL 
CRITERIA  
 
CONTENT 
MAJOR 
FINDINGS  
 
SYNTHESIS OF 
STUDIES  
 
COHERENCE 
RECOMMEND
ATIONS  
 
SUMMARY/ 
CONCLUSION 
 
 
Neither 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Sarff, M. & Gold, 
J., 2010 
 
 
 
Review 
pharmacologic
al strategies for 
the treatment 
of AWS in 
ICU patients. 
Review the 
pathophysiolog
y, diagnosis, 
and treatment 
of alcohol 
withdrawal 
syndrome. 
 
  
Alcohol 
Withdrawal 
Syndrome 
(AWS) – 
physiologic 
symptoms that 
occur due to the 
abrupt disuse or 
reduction of 
alcohol 
consumption.  
DT’s – delirium, 
autonomic 
hyperactivity, & 
alcohol 
hallucinosis 
 Cited supporting 
and opposing 
studies, classic 
studies, literature 
organized 
logically by topic 
+ 4 clinical states of 
alcohol 
withdrawal – 
autonomic 
hyperactivity, 
hallucinations, 
neural excitation, 
& DT’s. 
Symptoms can 
occur within 6 
hours, peak 
within 24 -48 hrs. 
30% - alcoholic 
hallucinosis, 10% 
alcohol 
withdrawal 
seizures, 5% - 
develop DT’s 
within 48 to 72 
hrs after last 
drink. High risk 
Benzodiaze-
pines – primary 
agent to treat 
AWS.   
Hydrate patients 
(volume 
depleted), 
thiamine, 
glucose, and 
carbohydrates – 
(many 
malnourished) 
 
Delerium in 
ICU patient 
could have 
another etiology 
other than 
alcohol 
withdrawal.  
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for AWS and DTs 
is a personal or 
family history of 
AWS and DTs. 
Genetics and race 
play a role. 
Sepsis and other 
conditions have 
similar signs 
and symptoms 
as AWS.  
 
 
TABLE OF EVIDENCE: EFFICACY OF AN EMERGENCY DEPARTMENT-BASED MULTICOMPONENT INTERVENTION 
FOR SMOKERS WITH SUBSTANCE USE DISORDERS  
RESEARCH  
 
REVIEW 
 
NEITHER 
AUTHOR/ 
YEAR 
 
PURPOSE 
  
TYPE OF 
STUDY  
 
KEY 
DEFINITIONS  
 
CREDIBILITY 
SETTING  
 
REVIEW 
BOUNDARIES  
 
 
QUALITY 
DATA 
COLLECTION 
METHODS 
APPRAISAL 
CRITERIA  
 
CONTENT 
MAJOR 
FINDINGS  
 
SYNTHESIS OF 
STUDIES  
 
COHERENCE 
RECOMMEND
ATIONS  
 
SUMMARY/ 
CONCLUSION 
 
 
Research 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Bernstein, S., 
Bijur, P., 
Cooperman, N., 
Jearld, S., 
Arnsten, J., 
Moadel, A., & 
Gallagher, E., 
2013.  
 
 
 
 
To determine 
efficacy of 2 
different 
smoking 
cessation 
interventions 
  
 
Subgroup 
analysis trial, 
340 subjects who 
tested + for 
alcohol abuse or 
illicit drug use 
were randomized 
to either usual 
care (UC) or 
enhanced care 
(EC) groups. 
EC consists of an 
intensive 
SBIRT-type 
intervention and 
nicotine 
 An urban, 
academic hospital 
emergency 
department 
Secondary 
analysis of 
data, ICD9 
diagnosis for 
ED visit. 
Modified 
Patient Health 
Questionnaire 
2- depression 
screen, 
Tobacco 
history – Stage 
of Change, 
Fagerstrom 
Test for 
nicotine 
dependence, 
After 3 months, 
substance users  
receiving EC 
were more likely 
to be tobacco 
abstinent than 
those receiving 
UC & to self-
identify as 
nonsmokers. 
 
 
Concurrent 
alcohol or 
substance abuse 
should not 
prevent 
initiation of 
tobacco 
dependence 
treatment in the 
ED. 
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replacement 
therapy 
Rapid Alcohol 
Problems 
Screen, Rapid 
Drug Problem 
Screen. End 
point – tobacco 
abstinence at 3 
months, doubly 
entered data 
imported into 
SPSS 16.0, 
univariate data 
– means and 
medians. 
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TABLE OF EVIDENCE: BLOOD ALCOHOL CONCENTRATION FOR MONITORING ETHANOL TREATMENT TO PREVENT 
ALCOHOL WITHDRAWAL IN THE INTENSIVE CARE UNIT  
RESEARCH  
 
REVIEW 
 
NEITHER 
AUTHOR/ 
YEAR 
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STUDY  
 
KEY 
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SETTING  
 
REVIEW 
BOUNDARIES  
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DATA 
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METHODS 
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STUDIES  
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SUMMARY/ 
CONCLUSION 
 
Research 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Eggers,V., Tio, J., 
Neumann, T., 
Pragst, F., Müller, 
C., Schmidt, L., 
…& Spies, C.,  
 2002 
 
To evaluate the 
difference in 
ethanol dose 
and levels 
between 
patients who 
developed 
AWS and 
those treated 
successfully in 
the ICU 
 
  
Prospective, 
observational 
study, 
retrospective 
post hoc analysis 
 ICU – 32 
alcohol-
dependent post- 
surgical 
admissions to the 
ICU 
Prospective, 
observational 
study, 
retrospective 
post hoc 
analysis 
 
IV ethanol 
prophylaxis was 
not successful in 
preventing AWS 
 
 
 
Titrate 
individual doses 
by closely 
monitoring the 
patient’s clinical 
status. Add 
additional 
medications to 
counteract AWS 
if higher ethanol 
doses are 
required. 
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Lotfipour S., 
Howard J., 
Roumani S., 
Hoonpongsimano
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Chakravarthy B., 
& Andykzeul, B., 
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To assess 
effectiveness 
of 
computerized 
alcohol 
screening and 
brief 
intervention 
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compared to 
medical 
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(MSE) by 
triage RN 
 
  
Retrospective 
review 
N=5835 
 Emergency 
Department 
Retrospective 
review of 
CASI and 
MSE 
databases. 
Alcohol Use 
Disorders 
Identification 
Test Scores 
using 
McNemar’s 
Test. 
CASI – increased 
detection of at- 
risk drinking over 
MSE. P<0.05, CI 
95% 
MSE – found 
2.5% at-risk 
drinkers. CASI – 
found 11.5%.  
 
In 18 to 20 year 
olds, MSE found 
1.8% at-risk 
drinkers and 
CASI found 
15.94% 
 
 
CASI is a good 
method for 
alcohol 
screening of 
adults 
(including 
underage 
drinkers 18 -20 
years old) in the 
emergency 
department 
setting  
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Neither  
 
 
 
 
 
 
 
 
 
 
 
 
McCormack, 
R.,Williams, A., 
Goldfrank, L., 
Caplan, A., Ross, 
S., & Rotrosen, J., 
2013 
 The need to 
provide 
comprehen-
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the whole 
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social factors, 
determinants 
of health 
contribute to 
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improve health 
and social 
outcomes for 
individuals 
disabled by 
alcohol use.  
Collaboration 
between the 
Department of 
Emergency 
Medicine, 
Department of 
Medical Ethics 
& Population 
Health, the 
Department of 
Psychiatry & the 
NY School of 
Medicine. 
Collaboration 
between the ED 
and other hospital 
departments 
(including 
inpatient 
psychiatry) & 
community 
agencies.  
Discussed 
addictions, cost 
to the 
individual, 
hospitals, and 
community. 
Although 
substance use 
disorders are 
included as 
diagnoses in 
the DSM-V, 
the law does 
not 
consistently 
involuntarily 
commit 
patients for 
substance use 
disorders.  
 
+  
Issue of 
Autonomy vs 
unable to care 
for self was 
discussed.  
 
Brief 
Involuntary 
commitment 
can permit time 
for the person to 
gain insight and 
motivation for 
treatment.  
 
Need for 
comprehensive 
assessment, 
coordinated tx 
and discharge 
planning 
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Awissi, D., 
Lebrun, G., 
Coursin, D, 
Riker, R., & 
Skrobik, Y., 2013 
to 
systematically 
review ICU 
literature to 
identify AWS 
risk factors, 
tools validated 
for AWS 
detection, 
prevention,  
treatment 
approaches, & 
appropriate 
outcomes 
among 
critically ill 
patients. 
  
AWS, DT’s, &  
Delirium – all 
defined in 
previous studies.  
Of 112 eligible 
articles, a 
total of 34 articles 
met -final search 
criteria 
Regarding 
AWS, DT’s, 
and alcohol 
withdrawal 
seizures, a 
limited amount 
of high quality 
data exists. All 
alcohol 
withdrawal 
data was 
labeled AWS. 
Of the 112 
articles, 26 
were chosen, 
after review of 
references 8 
more -34 
articles total or 
review.  
 
Alcohol 
dependent 
patients 
have higher 
infection, septic 
shock, and sepsis 
and rates, are 
more likely to be 
admitted to the 
ICU, more likely 
to  die in the 
hospital, and cost 
more in hospital 
resource dollars 
than patients not 
admitted to ICU 
for 
alcohol-related 
problems. 
 
Estimated 
prevalence of 
chronic 
alcoholism -  
The treatment of 
AWS is 
associated with 
increased ICU 
complication 
rates and 
increased 
resource 
utilization.  
No screening 
tools for 
withdrawal have 
been validated 
in the ICU. 
Early and 
aggressive 
titration of meds 
per symptoms is 
the only feature 
associated with 
improved 
treatment 
outcomes. 
55 ALCOHOL DETOXIFICATION CLINICAL PATHWAYS 
 
 
9/1/2014 
 
affects up to 20–
40 % of 
hospitalized 
patients & 50–60 
% 
of trauma 
patients.  
 
High-quality data 
for how best to 
prevent, diagnose, 
and treat AWS in 
the ICU is 
limited.  
 
ICU-specific 
guidelines have 
not been 
published. 
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Walsh, J., Flegel, 
R., Atkins, R., 
Cangianelli, L., 
Cooper, C., 
Welsh, C., & 
Kerns, T., 2005 
 
 To determine 
the incidence 
and prevelance 
of drug, 
alcohol, and 
combination 
drug and 
alcohol use 
among (motor 
vehicle crash) 
MVC victims  
  
90-day study. 
N=108, 72.2% 
male, 62% white 
 
Level 1 Trauma 
Center 
 
 
 
65.7% tested + 
for drugs and or 
alcohol.  
 
One half tested + 
for drugs other 
than alcohol. 
 
1:4 tested + for 
alcohol also 
tested + for 
marijuana. 
 
30.6% of all 
injured drivers 
tested + for 
alcohol.  
Traffic safety 
initiatives 
should focus not 
only on alcohol, 
but on alcohol 
and other drugs 
as well.  
Young males 
are the most at 
risk driving 
group. 
 
Drivers testing 
+ for cocaine, 
opiates, and 
benzos were > 
35 years of age 
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Seitz, H. & 
Maurer, B., 2007 
 Review of 
epidemiologica
l studies 
examining 
alcohol 
consumption 
and an 
increased risk 
of breast 
cancer 
ADH1B and 
ADH1C – 
polymorphic 
ADH genes 
  Positive 
association 
between alcohol 
consumption and 
an increased 
breast cancer risk.  
 
4% of newly 
diagnosed breast 
cancer a result of 
chronic alcohol 
intake.  
 
1999 study – 315 
pre-menapausal 
women, breast 
cancer risk higher 
in women that 
had 2 copies of 
the ADH1C 
allele. 
 
Acetaldehyde 
produced during 
alcohol 
metabolism may 
contribute to 
alcohol 
associated 
breast cancer 
development. 
 
Women with 
high levels of 
daily alcohol 
consumption 
with ADH1C 
allele at high 
risk of 
developing 
breast cancer. 
 
Alcohol 
increases serum 
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2000 study – 
found no effect of 
the ADH1C on 
breast cancer risk.  
2006 study – 1, 
000 breast cancer 
patients, 1,100 
control subjects –
women with 
alcohol 
consumption = to 
1 to 2 drinks a 
day, increased 
risk for breast 
cancer.  
estrogen & may 
contribute to 
alcohols 
carcinogenic 
actions. 
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Stephens, J., 
Liles, E., Dancel, 
R., Gilchrist, M., 
Kirsch, J., & 
DeWalt, D., 2014 
To develop a 
standardized 
protocol for 
hospitalists to 
determine 
Prospective 
observational 
evaluation of 
protocol 
implementation 
805 bed academic 
hospital  
Comparison of 12 
months prior to 
protocol 
Review of 
literature, task 
force, reviewed 
data by DRG 
codes and 
Slight increase in 
LOS and 
readmission rates, 
however the 
decrease in 
A standardized 
protocol for 
patients 
requiring 
alcohol 
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 whether to 
refer patients 
requesting 
alcohol 
detoxification  
to inpatient or 
outpatient 
treatment.  
Alcohol 
detoxification, 
alcohol 
withdrawal, 
hospital 
medicine, quality 
improvement 
 
 
implementation 
data to 21 months 
after protocol 
implementation 
data 
ICD-9 codes, 
reviewed the 
last 20 
consecutive 
admissions 
after protocol 
implementatio
n 
 
 
 
inpatient 
admissions by 3 a 
month resulted 
in organizational 
savings 
 
 
 
 
detoxification 
assists 
hospitalists in 
decision making 
and saved the 
hospital money 
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National Institute 
on Disability and 
Rehabilitation 
Research 
(NIDRR), 2010 
To improve 
patient 
outcomes for 
those with 
serious mental 
illness and co-
Medical homes     
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occurring 
medical 
conditions 
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Figure 2. Proposed process improvement project using the Theory of Symptom Management framework. 
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Table 3. Process Improvement Participants 
 
 
 
 
 
Name Department/Unit Job Title Role on Team 
Venkata Allada Medical Hospitalist/Inova Loudoun Hospital MD Leader 
Margaret Arotimi Nursing/ Psychiatry Inova Mt. Vernon Hospital Nurse Manager member 
Patricia Baker Winchester Medical Center/Heart and Vascular Clinical Nurse Specialist member 
Michelle Brahaney  Inova Health System/Informatics Informatics Analyst member 
Maureen Fowler Nursing/Inpatient Psychiatry and Substance Abuse Director member 
Kenneth Frese    
Nursing/Medical Surgical Unit/Inova Loudoun 
Hospital 
Clinical Nurse Specialist  Leader 
Kenneth Geoly  Inova Health System/Clinical Informatics  MD  Leader 
Robin Jackson Nursing Administration/Inova  Clinical Nurse Specialist  member 
Marissa Jamarik Nursing Administration/Inova Loudoun Hospital  Senior Director member 
Eugenia Shapiro-
Mathews 
 Inova Informatics/Inova Loudoun Hospital  Sr Systems Analyst  member 
Matthew Tibbs  Nursing Informatics/Inova Health System 
 EPIC certified systems 
analyst 
 member 
Debbie Wagner  Pharmacy/Inova Loudoun Hospital Pharmacy Manager  member 
Kelly Webster  Nursing/ICU Inova Loudoun Hospital Nurse Manager  member 
Thomas Wise Chairman, Dept of Psychiatry/Inova Fairfax Hospital  MD   member 
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Table 4. Data Retrieval Form Alcohol Detoxification Clinical Pathways   Protocol Number:                      
IRB # 
ID Number_________ 
 
ALCOHOL DETOXIFICATION CLINICAL PATHWAYS  
DATA RETRIEVAL GUIDE INFORMATION TO ABSTRACT FROM RECORD 
 
Date & Time of Admission   __  __ / __ __ /  __  __  __  __   Time __________ □AM    □PM 
                                                M  M    D   D     Y   Y   Y     Y 
 
Admitting diagnosis _____________________________________________ 
 
Age    ______ 
Gender        □ male         □ female 
Date & Time of CIWA order __  __ / __ __  /  __  __  __  __  Time __________ □AM    □PM 
                                                   M  M   D   D      Y   Y   Y    Y 
Restraint use during stay:  □ yes         □ no 
 
Transfer to the Intensive Care Unit:  □ yes      □ no    
if yes: 
 Intubation:     □ yes         □ no 
Total length of stay in ICU ______________ 
 
Date & Time of Discharge   __  __ / __ __  /  __  __  __  __   Time __________ □AM    □PM 
                                                M  M   D   D      Y   Y   Y    Y 
 
Total hospital length of stay: ___________________ 
 
 
Reviewers/Abstractors _________________________________________________ 
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Table 5. Definitions of Terms  
 
 
Clinical Pathway – a standardized clinical approach individualized based on presenting symptoms and patient history that includes a 
standardized CIWA-Ar and Moderate Detoxification Order Set.  
Clinical Institute Withdrawal Assessment for Alcohol (CIWA-Ar) – an instrument used to quantify the alcohol withdrawal 
syndrome, monitor the progression of symptoms, and identify individuals at risk for alcohol withdrawal. Symptoms are scored and 
pharmacological interventions taken when indicated to prevent the progression to advanced stages of withdrawal.    
Moderate Detoxification Order Set - standard order set for detox population. It is intended to standardize the clinical management of 
individuals requiring alcohol detoxification.  
Quality Advisor Program – is a trademark application that enables hospitals to analyze patient data for comparison, benchmarking, 
and quality monitoring. Its use enables hospitals to compare their performance internally and externally with other hospitals, comply 
with regulatory requirements, identify patterns and trends, and improve the quality of healthcare delivery. 
Standard Product List (SPL) resource facility report – is a facility bed charge report that enables identification of a population 
based on their physical location in the hospital, for example, the intensive care unit, by filtering using bed charge code and identifies 
the percentage of detoxification patients requiring transfer to ICU.   
EBP approach – An EBP approach utilizes best practice guidelines and the best available research to assess a particular clinical 
situation and improve current clinical practice. 
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High Risk CIWA-AR 
For use only in ICU 
General 
Vital Signs/Pulse Ox/Pain Assessments 
Vital signs Routine, Every hour, Increase to every 15 minutes if  
patient requiring more than hourly pm dosing 
Continuous Pulse Oximetry Routine, Continuous 
Nursing 
Notify 
Notify physician (specify) Routine, Until discontinued, Starting today, Notify for: 
HR less than 50 or greater than 120 BPM not 
controlled by dosing schedule, 
SBP less than 90 or greater than 180 mmHG, 
RR less than 8 or greater than 30 breaths/min, 
Temperature greater than 38.6 C if not controlled by 
dosing schedule, 
Oxygen saturation less than 92% 
Altered mental status, ataxia, pronounced lethargy, 
severe agitation, hallucinations, or paranoia, 
CIWA-Ar score not improved or worse after 2 hours of 
treatment, 
CIWA-Ar score greater than 18, or a score of greater 
than 15 x 2 consecutive assessments, 
Diaphoresis if not controlled by dosing schedule, 
Other: 
Nursing Asssessments 
Intake and Output Routine, Every hour 
CIWA Scale Routine, Every shift, Starting today, AR Score 
Document before each Lorazepam, 
Chlordiazepoxide admin and with VS 
CIWA Scale Routine, Every shift, Starting today, AR Score 
Discontinue Lorazepam, Chlordiazepoxide when 
CIWA score is less than 8 x 24 hours consecutively 
CIWA Scale Routine, Every shift, Starting today, AR Score If score 
less than 8, hold Lorazepam, Chlordiazepoxide and 
reassess q 4 hours 
CIWA Scale Routine, Every shift, Starting today, CIWA-Ar Score 
Reassess Q4H for score less than 8 
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CIWA Scale Routine, Every shift, Starting today, CIWA-Ar Score 
Reassess Q1H for score 8-15 until score is less than 
8, then reassess Q2H x 24 hours 
Precautions 
Seizure precautions Routine, Continuous For Until specified 
Aspiration precautions Routine, Continuous 
Respiratory 
Oxygen Therapy (Single Response) 
Nasal Cannula Low-Flow (5 LPM or less) Routine, Continuous 
FLOW Start at: (Liters per minute): 2 
Titrate to maintain SPO2: 
Indications: 
Oxygen 6LPM or more RT eval & recommend Routine, Once (RT) 
Inova Blood Gas 
Blood gas, arterial Routine, Once 
IV Fluids 
Standard Solutions 
dextrose 5 %-0.45 % sodium chloride infusion at 100 mL/hr, Intravenous, Continuous 
dextrose 5 %-0.9 % sodium chloride infusion at 100 mL/hr, Intravenous, Continuous 
0.45% NaCl infusion at 100 mL/hr, Intravenous, Continuous 
0.9% NaCl infusion at 100 mL/hr, Intravenous, Continuous 
lactated ringers infusion at 100 mL/hr, Intravenous, Continuous 
Inova Potassium Solutions 
dextrose 5 % and 0.45 % NaCl with KCl 10 mEq 
infusion 
at 100 mL/hr, Intravenous, Continuous 
dextrose 5 % and 0.45 % NaCl with KCl 20 mEq 
infusion 
at 100 mL/hr, Intravenous, Continuous 
dextrose 5 % and 0.45 % NaCl with KCl 30 mEq 
infusion 
at 100 mL/hr, Intravenous, Continuous 
dextrose 5 % and 0.45 % NaCl with KCl 40 mEq 
infusion 
at 100 mL/hr, Intravenous, Continuous 
dextrose 5 % and 0.9% NaCl with KCl 10 mEq 
infusion 
at 100 mL/hr, Intravenous, Continuous 
dextrose 5 % and 0.9 % NaCl with KCl 20 mEq 
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infusion 
at 100 mL/hr, Intravenous, Continuous 
dextrose 5 % and 0.9% NaCl with KCl 30 mEq 
infusion 
at 100 mL/hr, Intravenous, Continuous 
dextrose 5 % and 0.9 % NaCl with KCl 40 mEq 
infusion 
at 100 mL/hr, Intravenous, Continuous 
0.9% NaCl with KCl 10 mEq infusion at 100 mL/hr, Intravenous, Continuous 
0.9 % NaCl with KCl 20 mEq infusion at 100 mL/hr, Intravenous, Continuous 
0.9% NaCl with KCl 30 mEq infusion at 100 mL/hr, Intravenous, Continuous 
0.9 % NaCl with KCl 40 mEq infusion at 100 mL/hr, Intravenous, Continuous 
Inova MVI Solutions (Single Response) 
dextrose 5% and 0.45% NaCl with M.V.I. Adult 
10 mL, thiamine 100 mg, folic acid 1 mg infusion 
Intravenous, Daily 
Alternate daily with other IV fluids. 
dextrose 5% and 0.9 % NaCl with M.V.I. Adult 10 
mL, thiamine 100 mg, folic acid 1 mg infusion 
Intravenous, Daily 
Alternate daily with other IV fluids. 
sodium chloride 0.9 % 1,000 mL with M.V.I. Adult 
10 mL, thiamine 100 mg, folic acid 1 mg infusion 
Intravenous, Daily 
Alternate daily with other IV fluids. 
ChlordiazePOXIDE (Librium) 
chlordiazePOXIDE (Librium) (Single Response) 
chordiazEPOXIDE (Librium) For Patients greater 
than 65 years old 
"Followed by" Linked Panel 
chlordiazePOXIDE (LIBRIUM) capsule 50 mg, Oral, Every 12 hours scheduled, Starting 
today, For 4 Doses 
Day 1 and Day 2 
chlordiazePOXIDE (LIBRIUM) capsule 25 mg, Oral, Every 12 hours scheduled, For 4 
Doses 
Day 3 and Day 4. 
chlordiazePOXIDE (LIBRIUM) capsule 25 mg, Oral, Once, Starting 6/2/15 at 10:00 AM, 
For 1 Doses 
Day 5. 
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ChlordiazePOXIDE (Librium) For Patients less 
than 65 years old 
"Followed by" Linked Panel 
chlordiazePOXIDE (LIBRIUM) capsule 100 mg, Oral, Every 12 hours scheduled, Starting 
today, For 4 Doses 
Day 1 and Day 2 
 
 
chlordiazePOXIDE (LIBRIUM) capsule 50 mg, Oral, Every 12 hours scheduled, For 4 
Doses 
Day 3 and Day 4 
chlordiazePOXIDE (LIBRIUM) capsule 50 mg, Oral, Once, Starting 6/2/15 at 10:00 AM, 
For 1 Doses 
Day 5 
chlordiazePOXIDE (LIBRIUM) capsule 50 mg, Oral, Every 6 hours, Starting today 
Medications - Adjunctive Therapy 
Haloperidol is contraindicated in patients with underlying QT prolongation and concurrent use of 
medications that cause QT prolongation. 
Inova Adjunctive Meds 
haloperidol lactate (HALDOL) injection 5 mg, Intravenous, Every 1 hour PRN, Agitation, 
CIWA-Ar greater than 8 
Adjunctive therapy. Maximum of 35 mg/day. Hold for 
QTc greater than 0.44 msec. 
atenolol (TENORMIN) tablet 50 mg, Oral, Daily 
Adjunctive therapy 
magnesium sulfate 1g in dextrose 5% 100mL 
IVPB (premix) 
1 g, Intravenous, for 60 Minutes, Every 1 hour PRN, 
Other, For Magnesium sulfate less than 1.5 mg/dL, 
give 1 gm per hour x 4 doses (4gm/4hours) 
cloNIDine (CATAPRES) tablet 0.1 mg, Oral, Every 6 hours PRN, Other, SBP greater 
than 190 or DBP greater than 105 mmHg 
multivitamin (MULTIVITAMIN) tablet 1 tablet, Oral, Daily 
folic acid (FOLVITE) tablet 1 mg, Oral, Daily 
thiamine (B-1) tablet 100 mg, Oral, Daily 
thiamine (B-1) injection 100 mg, Intramuscular, Daily, For 3 Days 
LORazepam (Ativan) 
Inova LORazepam (ATIVAN) 
LORazepam (ATIVAN) injection 1-2 mg, Intravenous, As needed, Other, Per CIWA 
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score - See admin instructions, Starting today 
CIWA-Ar less than 8: give no lorazepam, reassess in 
60 minutes; reduce reassessment frequency to q2h x 
3 if CIWA-Ar remains less than 8 
CIWA-Ar 8-15: Lorazepam 1 mg IV every 15 min prn; 
reassess in 30 minutes X 2; reduce reassessment 
frequency to q1h if CIWA-Ar remains less than 8 
CIWA-Ar greater than 15: Lorazepam 2 mg IV every 
15 mins. PRN; reassess in 15 minutes x 3; reduce 
reassessment frequency to q30 mins if CIWA-Ar 
remains less than 15 
 
lorazepam (ATIVAN) 100 mg in sodium chloride 
0.9% 100mL infusion 
2-16 mg/hr, Intravenous, Continuous PRN, Other, Per 
CIWA score - See admin instructions 
Initiate drip if patient receives more than 2 PRN doses 
in 1 hour for score greater than 15 x 2; give 
Lorazepam 2 mg IV bolus and start drip at 2 mg/hr 
For CIWA-Ar score less than 8 x 2 consecutive 
assessments; reduce rate by 1 mg/hr until titrated off; 
return to PRN dosing 
For CIWA-Ar score 8-15; no change in infusion rate; 
reassess every 30 mins x 2 then q1h 
For CIWA-Ar greater than 15; bolus with Lorazepam 2 
mg IV and increase rate by 2 mg/hr to max rate of 16 
mg/hr; if max dose is reached, call MD; reassess in 
30 mins 
Laboratory 
Panels 
Basic Metabolic Panel Routine, Every morning, Starting today with First 
Occurrence Include Now For 3 Days 
Hepatic function panel Routine, Once For 1 Occurrences 
Hematology 
CBC and differential Routine, Once 
Protime-INR Routine, Once 
Anticoagulant within 48hours: 
APTT Routine, Once 
Anti-coagulant? 
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Chemistry 
Magnesium Routine, Once, Starting today For 1 Occurrences 
Phosphorus Routine, Every morning, Starting today with First 
Occurrence Include Now 
Vitamin B12 Routine, Once For 1 Occurrences 
Folate Routine, Once For 1 Occurrences 
TSH Routine, Once For 1 Occurrences 
Ammonia Routine, Once, Starting today For 1 Occurrences 
Cardiac Markers 
Troponin I Routine, Every 8 hours For 3 Occurrences 
Urine 
Rapid drug screen, urine Routine, Once 
Imaging 
Diagnostic X-Ray 
XR Chest AP Portable Routine, 1 time imaging For 1 
Is the patient pregnant? 
Reason for Exam: 
Is this a portable exam? 
Diagnostics 
Cardiology 
ECG 12 lead if Haloperidol (Haldol) dose 
exceeds 20mg in 24 hours 
Routine, Daily 
Reason for exam: 
If QTc interval is greater than 500 milliseconds, notify 
physician before administering Haloperidol 
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